1. Home
  2. SIMO vs MESO Comparison

SIMO vs MESO Comparison

Compare SIMO & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIMO
  • MESO
  • Stock Information
  • Founded
  • SIMO 1995
  • MESO 2004
  • Country
  • SIMO Hong Kong
  • MESO Australia
  • Employees
  • SIMO N/A
  • MESO N/A
  • Industry
  • SIMO Semiconductors
  • MESO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SIMO Technology
  • MESO Health Care
  • Exchange
  • SIMO Nasdaq
  • MESO Nasdaq
  • Market Cap
  • SIMO 1.3B
  • MESO 1.4B
  • IPO Year
  • SIMO 2005
  • MESO N/A
  • Fundamental
  • Price
  • SIMO $53.54
  • MESO $10.97
  • Analyst Decision
  • SIMO Strong Buy
  • MESO Buy
  • Analyst Count
  • SIMO 8
  • MESO 4
  • Target Price
  • SIMO $77.50
  • MESO $18.00
  • AVG Volume (30 Days)
  • SIMO 556.6K
  • MESO 163.9K
  • Earning Date
  • SIMO 04-29-2025
  • MESO 02-26-2025
  • Dividend Yield
  • SIMO 3.71%
  • MESO N/A
  • EPS Growth
  • SIMO 59.19
  • MESO N/A
  • EPS
  • SIMO 2.80
  • MESO N/A
  • Revenue
  • SIMO $780,733,000.00
  • MESO $5,670,000.00
  • Revenue This Year
  • SIMO $2.80
  • MESO $152.37
  • Revenue Next Year
  • SIMO $13.32
  • MESO $336.12
  • P/E Ratio
  • SIMO $19.15
  • MESO N/A
  • Revenue Growth
  • SIMO 10.84
  • MESO N/A
  • 52 Week Low
  • SIMO $37.21
  • MESO $5.78
  • 52 Week High
  • SIMO $85.87
  • MESO $22.00
  • Technical
  • Relative Strength Index (RSI)
  • SIMO 65.04
  • MESO 44.34
  • Support Level
  • SIMO $51.31
  • MESO $10.77
  • Resistance Level
  • SIMO $53.99
  • MESO $11.61
  • Average True Range (ATR)
  • SIMO 2.04
  • MESO 0.47
  • MACD
  • SIMO 1.35
  • MESO 0.09
  • Stochastic Oscillator
  • SIMO 96.90
  • MESO 27.68

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About MESO Mesoblast Limited

Mesoblast Ltd is a biotechnology company. It uses its proprietary technology platform to develop and commercialize allogeneic cellular medicines to treat complex diseases resistant to conventional standards of care and where inflammation plays a central role. The company's product candidates include; Ryoncil (remestemcel-L) for the treatment of steroid refractory acute graft versus host disease as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of cell technology platform for commercialization.

Share on Social Networks: